8 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Overview of Treatment Agents ... for COVID-19 - ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Analgesia and Sedation Medications ... due to #COVID19 ... #management #covid19 ... #treatment #sarscov2 ... sedative #analgesia #pharmacology
Paxlovid Drug-Drug Interactions
Before prescribing ritonavir-boosted nirmatrelvir (Paxlovid) for outpatient treatment of COVID-19, determine whether the patient
outpatient treatment of COVID ... receiving any of the medications ... Interactions #DDI #pharmacology ... #COVID19 #SARSCOV2 ... #COVID #outpatient
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... Select Proposed COVID ... Dosing #Table #COVID19 ... #Coronavirus #SARSCOV2 ... #Medications #JAMA
Hydroxychloroquine and Chloroquine in COVID19

Dosing:
Hydroxychloroquine:
 - 400mg PO BID on the first day, followed by 200mg
Chloroquine in COVID19 ... - Second line agent ... #Chloroquine #COVID19 ... #HCQ #Pharmacology ... #Management #Medications
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Anti-IL6 Agents ... Siltuximab) in COVID19 ... correlate with severe COVID ... #Pharmacology # ... Management #Medications
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Hepatitis C The new agents ... recommendations change frequently ... ambcarerx #HCV #Medications ... Classes #DAAs #Pharmacology
Pharmaceutical agents other than olmesartan have been reported to cause villous atrophy on occasion and are
Pharmaceutical agents ... to be the most frequent ... several other agents ... #Pharmacology #Drugs ... #Induced #Medications